Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden

被引:55
|
作者
Ufer, M [1 ]
Kimland, E
Bergman, U
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Div Clin Pharmacol, SE-14186 Stockholm, Sweden
[2] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany
[3] Stockholm Cty Council, Pharmacoepidemiol Ctr, LAKSAK, Stockholm, Sweden
[4] Huddinge Univ Hosp, Med Prod Agcy, Reg Adverse Drug React Ctr, Stockholm, Sweden
关键词
off-label; children; drug prescribing; paediatric; outpatient; adverse drug reaction;
D O I
10.1002/pds.858
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To investigate the extent and characteristics of off-label prescribing for paediatric outpatients among drugs reported to have caused an adverse reaction. Methods A retrospective, cross-sectional, observational analysis of spontaneous adverse drug reaction (ADR) reports in Sweden in the year 2000. We included all reports concerning drugs prescribed for outpatients younger than 16 years. Each ADR was classified with respect to its causality, seriousness and type of reaction. Off-label prescribing was evaluated with respect to age, dose, indication, formulation and route and frequency of administration. Results We identified 112 patient-linked reports corresponding to 158 ADRs of which 31% were serious. Antiasthmatic drugs were most frequently suspected as a cause of almost every third adverse reaction. The average proportion of off-label drug prescribing amounted to 42.4%. It was more frequently associated with serious than non-serious ADRs and mostly due to a non-approved age or dose. The most common clinical manifestations were psychiatric disorders and mucocutaneous inflammatory reactions. Conclusions Off-label prescribing for paediatric outpatients is common among drugs reported to have caused an ADR. It is suggested to further identify unlabelled drugs frequently contributing to, in particular serious ADRs in children for a proper benefit-fisk assessment of off-label drug use. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 50 条
  • [41] Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children: a prospective study
    Nguyen, Ka
    Plaisant, F.
    Beissel, A.
    Millaret, A.
    Vial, T.
    Gaillard, S.
    Claris, O.
    Kassai-Koupai, B.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 60 - 60
  • [42] Evaluation of spontaneous adverse event reports for drug abuse, misuse, dependence or off-label use attributed to pregabalin within the FDA adverse events reporting system (FAERS)
    Elkersh, Ahmed M.
    Salama, Mai M.
    Mekkawy, Mohamed A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 480 - 480
  • [43] A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs
    Smithburger, Pamela L.
    Buckley, Mitchell S.
    Culver, Mark A.
    Sokol, Sarah
    Lat, Ishaq
    Handler, Steven M.
    Kirisci, Levent
    Kane-Gill, Sandra L.
    [J]. CRITICAL CARE MEDICINE, 2015, 43 (08) : 1612 - 1621
  • [44] Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year
    Singh, Preeti
    Agrawal, Manju
    Hishikar, Rajesh
    Joshi, Usha
    Maheshwari, Basant
    Halwai, Ajay
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2017, 49 (06) : 432 - 437
  • [45] Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMl) A study protocol
    Nguyen, Kim An
    Mimouni, Yanis
    Jaberi, Elham
    Paret, Nathalie
    Boussaha, Inesse
    Vial, Thierry
    Jacqz-Aigrain, Evelyne
    Alberti, Corinne
    Guittard, Laure
    Remontet, Laurent
    Roche, Laurent
    Bossard, Nadine
    Kassai, Behrouz
    [J]. THERAPIE, 2021, 76 (06): : 675 - 685
  • [46] Thalomid® (Thalidomide) capsules -: A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing
    Clark, TE
    Edom, N
    Larson, J
    Lindsey, LJ
    [J]. DRUG SAFETY, 2001, 24 (02) : 87 - 117
  • [47] Thalomid® (Thalidomide) CapsulesA Review of the First 18 Months of Spontaneous Postmarketing Adverse Event Surveillance, Including Off-Label Prescribing
    Todd E. Clark
    Norma Edom
    Janice Larson
    Laura J. Lindsey
    [J]. Drug Safety, 2001, 24 : 87 - 117
  • [48] KNOWLEDGE OF OFF-LABEL DRUG USE IN CHILDREN: NATIONAL PAEDIATRIC SURVEY RESULTS (OL-PED STUDY)
    Ruiz, B.
    Pineiro, R.
    Cabrera, L.
    Cilleruelo, M. J.
    Mellado, M. J.
    Roman, E.
    Avendano, C.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 36 - 36
  • [50] The practice of off label prescribing and associated adverse drug reactions in pediatric inpatients in a tertiary care hospital in India
    Rajan, Rebecca
    Peter, Sharlin M.
    Kurian, Vincey M.
    Ansari, Roohinaz
    Pawar, Sunita
    Kalrao, Vijay
    [J]. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2019, 10 (01) : 29 - 34